A Phase II Multi-Center Study of Triple Therapy with Paclitaxel, S-1 and Cisplatin in Patients with Advanced Gastric Cancer

Publisher： Karger

E-ISSN： 1423-0232|80|1-2|76-83

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.1-2, 2011-06, pp. : 76-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

A Multicenter, Phase I Dose-Escalating Study of Docetaxel, Cisplatin and S-1 for Advanced Gastric Cancer (KDOG0601)

By  

Oncology, Vol. 75, Iss. 1-2, 2008-08 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Phase I Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 69, Iss. 3, 2005-10 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

Phase I and Pharmacokinetic Study of S-1 Combined with Weekly Paclitaxel in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 414-420

Karger

Access to resources Recommend Favorite

Phase II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable or Metastatic Gastric Cancer

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 37-41

Karger

Access to resources Recommend Favorite